52w high/low | ₹524.9 / ₹116.25 |
P/E ratio | 5380.71 |
Dividend | 0.27 |
ROE | 2.8 |
ROCE | 4.94 |
Face value | 10 |
Book value | ₹204.72Cr |
Market capital | ₹116.38Cr |
What is shareholding pattern? Who are shareholders?
What is a cash flow statement?
What is a balance sheet?
What is a profit and loss statement?
What are dividends?
What are bonuses?
Samrat Pharmachem Ltd is planning to de-merge its Second Unit in favour of newly formed company viz. Samrat Remedies Ltd w.e.f. April 1, 2004.